NCT01613261 2013-11-01Study of TAK-733 in Combination With Alisertib in Adult Patients With Advanced Nonhematologic MalignanciesMillennium Pharmaceuticals, Inc.Phase 1 Withdrawn
NCT00948467 2013-07-02Study of TAK-733 in Adult Patients With Advanced Nonhematologic MalignanciesMillennium Pharmaceuticals, Inc.Phase 1 Completed51 enrolled